Napo Therapeutics, S.p.A.
Quick facts
Phase 2 pipeline
- Crofelemer Powder for Oral Solution · Gastroenterology
Crofelemer is a plant-derived inhibitor of the sodium glucose cotransporter 2 (SGLT2)
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: